Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is First Financial Bancorp (FFBC) A Good Stock To Buy?

Page 1 of 2

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can’t match. So should one consider investing in First Financial Bancorp (NASDAQ:FFBC)? The smart money sentiment can provide an answer to this question.

Is First Financial Bancorp (NASDAQ:FFBC) a buy here? Prominent investors are in a bullish mood. The number of bullish hedge fund positions inched up by 3 recently. First Financial Bancorp (NASDAQ:FFBC) was in 11 hedge funds’ portfolios at the end of the third quarter of 2015. There were 8 hedge funds in our database with First Financial Bancorp (NASDAQ:FFBC) positions at the end of the previous quarter. A similar mood is reflected in the market trading behavior, with the shares of the company trading 6.35% higher during the last quarter. For an in-depth understanding of the hedge fund sentiment, we will cover hedgies that held positions in First Financial Bancorp (NASDAQ:FFBC), at the end of September.

The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article, we will examine companies such as ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), NBT Bancorp Inc. (NASDAQ:NBTB), and THE CHEMOURS COMPANY (NYSE:CC) to gather more data points.

Follow First Financial Bancorp (NASDAQ:FFBC)
Trade (NASDAQ:FFBC) Now!

According to most market participants, hedge funds are viewed as worthless, old financial vehicles of years past. While there are greater than 8000 funds trading today, our experts hone in on the aristocrats of this club, about 700 funds. These investment experts shepherd the majority of the hedge fund industry’s total capital, and by tailing their top stock picks, Insider Monkey has figured out a number of investment strategies that have historically outperformed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outperformed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to take a glance at the latest action encompassing First Financial Bancorp (NASDAQ:FFBC).

Hedge fund activity in First Financial Bancorp (NASDAQ:FFBC)

At the end of the third quarter, a total of 11 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 38% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Israel Englander’s Millennium Management has the biggest position in First Financial Bancorp (NASDAQ:FFBC), worth close to $12.2 million, corresponding to less than 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Porter Collins, Daniel Moses, and Vincent Daniel of Seawolf Capital, with a $3.6 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other professional money managers with similar optimism comprise Ken Gray and Steve Walsh’s Bryn Mawr Capital, Ken Griffin’s Citadel Investment Group, and Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!